Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajun Du

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
Analytical Chemistry|February 21, 2026
NIR-II Fluorescent Timer-Embedded Drug for Real-Time Tracing of Immunogenic Cell Death and Guiding Chemo-immunotherapyCaixia Wang, Siqi Zhang, Yuxin Xie, et al.
Nanoscale|June 16, 2026
Defective Nb<sub>2</sub>C MXene anchored Cu sites enhancing photocatalytic CO<sub>2</sub> reduction to ethanolJiajun Du, Jun Deng, Sharafat Ali, et al.
Sensors (Basel, Switzerland)|August 29, 2024
Doppler Radar Sensor-Based Fall Detection Using a Convolutional Bidirectional Long Short-Term Memory ModelZhikun Li, Jiajun Du, Baofeng Zhu, et al.
BMC Cancer|June 27, 2018
An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomyYing Wang, Xiao Qu, Ngar-Woon Kam, et al.
Biological Trace Element Research|December 20, 2024
Selenium-Enriched Aspergillus oryzae A02 Enhances Testicular Antioxidant Capacity in Mice by Regulating Intestinal Microbiota and Serum MetaboliteJiajun Du, Junyu Xue, Xutong Tian, et al.
Scientific Reports|October 14, 2017
Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancerFenglong Bie, Xiao Qu, Xudong Yang, et al.
Journal of Thoracic Disease|December 23, 2017
Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysisZhaofei Pang, Yufan Yang, Nan Ding, et al.
Medicine|November 16, 2017
Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinomaXiaowei Li, Keying Che, Liguang Wang, et al.
Oncotarget|April 22, 2017
Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapyXiao Qu, Zhinan Wu, Wei Dong, et al.
Scientific Reports|August 5, 2016
Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLCHongxin Cao, Wei Dong, Xiao Qu, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Analytical Chemistry|February 21, 2026
NIR-II Fluorescent Timer-Embedded Drug for Real-Time Tracing of Immunogenic Cell Death and Guiding Chemo-immunotherapyCaixia Wang, Siqi Zhang, Yuxin Xie, et al.
Nanoscale|June 16, 2026
Defective Nb<sub>2</sub>C MXene anchored Cu sites enhancing photocatalytic CO<sub>2</sub> reduction to ethanolJiajun Du, Jun Deng, Sharafat Ali, et al.
Sensors (Basel, Switzerland)|August 29, 2024
Doppler Radar Sensor-Based Fall Detection Using a Convolutional Bidirectional Long Short-Term Memory ModelZhikun Li, Jiajun Du, Baofeng Zhu, et al.
BMC Cancer|June 27, 2018
An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomyYing Wang, Xiao Qu, Ngar-Woon Kam, et al.
Biological Trace Element Research|December 20, 2024
Selenium-Enriched Aspergillus oryzae A02 Enhances Testicular Antioxidant Capacity in Mice by Regulating Intestinal Microbiota and Serum MetaboliteJiajun Du, Junyu Xue, Xutong Tian, et al.
Scientific Reports|October 14, 2017
Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancerFenglong Bie, Xiao Qu, Xudong Yang, et al.
Journal of Thoracic Disease|December 23, 2017
Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysisZhaofei Pang, Yufan Yang, Nan Ding, et al.
Medicine|November 16, 2017
Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinomaXiaowei Li, Keying Che, Liguang Wang, et al.
Oncotarget|April 22, 2017
Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapyXiao Qu, Zhinan Wu, Wei Dong, et al.
Scientific Reports|August 5, 2016
Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLCHongxin Cao, Wei Dong, Xiao Qu, et al.
Pageof 20